Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY.
Blood Adv. 2024 Jul 23;8(14):3745-3753. doi: 10.1182/bloodadvances.2024013460.
Serum ferritin (SF) concentration is the most widely used indicator for iron deficiency (ID). During pregnancy, the World Health Organization recently recommended SF thresholds for ID of <15 μg/L for the first trimester of pregnancy, based on expert opinion, and made no recommendations for the second and third trimesters. We examined the relationship of SF with 2 independent indicators of the onset of iron-deficient erythropoiesis, hemoglobin and soluble transferrin receptor 1, in cross-sectional data from US National Health and Nutrition Examination Survey for 1999 to 2010 and 2015 to 2018. We included 1288 pregnant women aged 15 to 49 years and excluded women with inflammation or potential liver disease. We used restricted cubic spline (RCS) regression analysis to determine SF thresholds for iron-deficient erythropoiesis. SF decreased during pregnancy; geometric mean SF was higher during the first and lower during the second and third trimesters. Using RCS analysis, the SF thresholds identified during pregnancy were <25.8 μg/L (18.1-28.5) during first trimester, <18.3 μg/L (16.3-22.9) during second trimester, and <19.0 μg/L (14.4- 26.1) during third trimester. These SF threshold levels track concentrations of hepcidin, the iron-regulatory hormone controlling the mobilization of iron stores. An SF concentration of <15 μg/L as the criterion for ID may underestimate the true prevalence of ID throughout pregnancy. In our study, an additional 1 of every 10 pregnant women would be recognized as iron deficient by using the physiologically based thresholds at SF of ∼25 μg/L during the first and ∼20 μg/L during the second and third trimesters.
血清铁蛋白(SF)浓度是铁缺乏症(ID)最常用的指标。最近,世界卫生组织根据专家意见建议,将妊娠早期 SF 诊断 ID 的阈值定为<15μg/L,但对妊娠第二和第三期未提出建议。我们利用美国 1999 年至 2010 年和 2015 年至 2018 年国家健康和营养调查的横断面数据,检验了 SF 与 2 种独立的缺铁性红细胞生成起始指标(血红蛋白和可溶性转铁蛋白受体 1)之间的关系。我们纳入了 1288 名年龄在 15 至 49 岁的孕妇,并排除了有炎症或潜在肝脏疾病的妇女。我们使用限制立方样条(RCS)回归分析来确定妊娠期间缺铁性红细胞生成的 SF 阈值。SF 在妊娠期间下降;第一期的几何平均 SF 较高,第二期和第三期较低。使用 RCS 分析,在妊娠期间确定的 SF 阈值为第一期<25.8μg/L(18.1-28.5)、第二期<18.3μg/L(16.3-22.9)、第三期<19.0μg/L(14.4-26.1)。这些 SF 阈值水平与控制铁储存动员的铁调节激素——hepcidin 的浓度相关。将 SF 浓度<15μg/L 作为 ID 的标准可能会低估整个妊娠期间 ID 的真实流行率。在我们的研究中,使用生理基础 SF 阈值(第一期约 25μg/L,第二期和第三期约 20μg/L),每 10 名孕妇中就会额外识别出 1 名缺铁。